| Guidance on Therapeutic Equivalence Requirements |
| Guidance on Stability Testing for Finished Pharmaceutical Products and Active Pharmaceutical Ingredient |
| Guidance on Registration of Fixed Dose Combination for Human Pharmaceutical Products |
| Guidance on Product Quality Review (PQR) Requirements for Generic Human Medicinal Products |
| Guidance on Procedural Aspects for Applications for Marketing Authorization of Human Pharmaceutical Products |
| Guidance on Naming of Human Pharmaceutical Products |
| Guidance on Format and Content of Summary of Products Characteristics (SmPC) |
| Guidance on Format and Content of Patient Information Leaflet |
| Guidance on Format and Content of Labels for Human Pharmaceutical Products |
| Guidance on Application for BCS Biowaiver |
Toll Free: 9707
info@rwandafda.gov.rw
Nyarutarama Plaza, KG 9 Avenue
